Status:
UNKNOWN
Brimonidine Tartrate for Pterygium Surgery
Lead Sponsor:
Uptown Eye Specialists
Conditions:
Pterygium
Subconjunctival Hemorrhage
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Pterygium excision and conjunctival autograft surgery is commonly done to treat pterygiums. Excessive bleeding during the procedure creates a challenging operating field, prolongs surgery time, and pr...
Detailed Description
During pterygium excision and conjunctival autograft surgery, incision into the conjunctiva of the operated eye causes a significant amount of subconjunctival hemorrhage. Brimonidine-tartrate is a sel...
Eligibility Criteria
Inclusion
- All patients over age 18 who are scheduled for pterygium surgery who have provided informed consent, in accordance with application regulations and guidelines
Exclusion
- Patients who are on anticoagulation or antiplatelet therapy
- Patients on monoamine oxidase (MOA) inhibitor therapy
- Patients who have undergone any conjunctival surgery in the past
- Any complication during pterygium excision
Key Trial Info
Start Date :
February 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2021
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT04683159
Start Date
February 1 2021
End Date
September 1 2021
Last Update
December 24 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.